Chimerix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Chimerix and buy or sell other stocks, ETFs, and their options commission-free!

About CMRX

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. 

CEO
Michael T. Andriole, MBA
CEOMichael T. Andriole, MBA
Employees
81
Employees81
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
2000
Founded2000
Employees
81
Employees81

CMRX Key Statistics

Market cap
787.47M
Market cap787.47M
Price-Earnings ratio
-8.67
Price-Earnings ratio-8.67
Dividend yield
—
Dividend yield—
Average volume
—
Average volume—
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$8.55
52 Week high$8.55
52 Week low
$0.75
52 Week low$0.75

People also own

Based on the portfolios of people who own CMRX. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Plug Power
Tonix Pharmaceuticals
Tilray Brands
NIO
Ocugen, Inc
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.